Zobrazeno 1 - 10
of 53
pro vyhledávání: '"KONISHI, Tsuzumi"'
Autor:
Oshima, Masashi, Washino, Satoshi, Nakamura, Yuhki, Konishi, Tsuzumi, Saito, Kimitoshi, Miyagawa, Tomoaki
Publikováno v:
In Prostate International March 2023 11(1):13-19
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Konishi, Tsuzumi1 (AUTHOR), Washino, Satoshi1 (AUTHOR) suwajiisan@yahoo.co.jp, Okochi, Tomohisa2 (AUTHOR), Miyagawa, Tomoaki1 (AUTHOR)
Publikováno v:
International Journal of Urology. Sep2022, Vol. 29 Issue 9, p1031-1037. 7p.
Autor:
HAYASE, Takanori, WASHINO, Satoshi, MAYUMI, Shozaburo, YAZAKI, Kai, NAKAMURA, Yuki, OSHIMA, Masashi, KONISHI, Tsuzumi, SAITO, Kimitoshi, MIYAGAWA, Tomoaki
Publikováno v:
泌尿器科紀要. 67(6):239-243
A 71-year-old man presented with neck pain. He was diagnosed with renal cell carcinoma of the left kidney with lung and bone metastases. After laparoscopic left nephrectomy, nivolumab plus ipilimumab was introduced as a first-line therapy for interme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::7635a189964daf11da64c0b6dfe8f968
http://hdl.handle.net/2433/264501
http://hdl.handle.net/2433/264501
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shirai, Katsuyuki, Suzuki, Masato, Akahane, Keiko, Takahashi, Yuta, Kawahara, Masahiro, Yamada, Erika, Wakatsuki, Masaru, Ogawa, Kazunari, Takahashi, Satrou, Minato, Kyosuke, Hamamoto, Kohei, Saito, Kimitoshi, Oshima, Masashi, Konishi, Tsuzumi, Nakamura, Yuhki, Washino, Satoshi, Miyagawa, Tomoaki
Publikováno v:
In vivo (Athens, Greece). 34(3):1289-1295
The aim of this study was to evaluate the dose-volume histogram parameters for late hematuria and rectal hemorrhage in patients receiving radiotherapy after radical prostatectomy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::bb29ffc16dc4cb09d4bd24fa6c9e6e29
https://repo.qst.go.jp/records/79966
https://repo.qst.go.jp/records/79966
Autor:
Yamada, Hodaka, Washino, Satoshi, Suzuki, Daisuke, Saikawa, Rika, Tonezawa, Shiori, Hagiwara, Rie, Funazaki, Shunsuke, Yoshida, Masashi, Konishi, Tsuzumi, Saito, Kimitoshi, Miyagawa, Tomoaki, Hara, Kazuo
Additional file 1. Clinical characteristics between patients with ICI-induced hypopituitarism who presented with hypereosinophilia and those who did not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3a5bba20a992dd758fb2923d28d867
Autor:
Yamada, Hodaka, Washino, Satoshi, Suzuki, Daisuke, Saikawa, Rika, Tonezawa, Shiori, Hagiwara, Rie, Funazaki, Shunsuke, Yoshida, Masashi, Konishi, Tsuzumi, Saito, Kimitoshi, Miyagawa, Tomoaki, Hara, Kazuo
Additional file 2: Supplemental Figure 1. Total number of irAEs perpatient (A) and duration (days) from the initial administration of nivolumabplus ipilimumab to the onset of symptoms (B).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af89562fe423da6086d5ba5d2eedd7ec
Autor:
Yamada, Hodaka, Washino, Satoshi, Suzuki, Daisuke, Saikawa, Rika, Tonezawa, Shiori, Hagiwara, Rie, Funazaki, Shunsuke, Yoshida, Masashi, Konishi, Tsuzumi, Saito, Kimitoshi, Miyagawa, Tomoaki, Hara, Kazuo
Additional file 3: Supplemental Figure 2. Overall survival (OS) after startingcombination therapy with nivolumab plus ipilimumab in patients with renal cellcarcinoma and immune checkpoint inhibitor-induced hypopituitarism. OS at 35 months was 90.9% (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d1ba52e5bb1365d526accbbb130eca5